Citation CADTH. Combination use of insulin and fipeptidyl peptidase-4 (DDP-4) inhibitors in Type 2 diabetes: clinical effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions Four systematic reviews and seven randomized controlled trials were identified regarding the clinical efficacy and safety of DPP-4 inhibitors used in combination with insulin for patients withinadequate glycemic control on a basal or biphasic insulin regimen. Indexing Status Subject indexing assigned by CRD MeSH Diabetes Mellitus, Type 2s; Dipeptidyl-Peptidase IV Inhibitors; Insulin Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32015000229 Date abstract record published 05/03/2015 |